The Rac-cGMP Signaling Pathway
Rac-cGMP 信号通路
基本信息
- 批准号:7939038
- 负责人:
- 金额:$ 8.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAllosteric RegulationBiochemicalBlood VesselsCardiovascular DiseasesCardiovascular PhysiologyCatalytic DomainCyclic GMPCytoskeletal ModelingDevelopmentDiseaseFigs - dietaryGuanosine Triphosphate PhosphohydrolasesGuanylate CyclaseHandHealthHumanIn VitroInvestigationLinkMediatingMembraneMolecularMonomeric GTP-Binding ProteinsPathway interactionsPhosphotransferasesPhysiologicalPhysiological ProcessesProtein KinaseReceptor SignalingReportingResearchSecond Messenger SystemsSignal PathwaySignal TransductionSignaling MoleculeSystemVascular Endothelial Growth FactorsVascular Permeabilitiesatrial natriuretic factor receptor Acell motilityin vivomouse modelnovelp21 activated kinasepublic health relevancereceptorresponsesecond messenger
项目摘要
DESCRIPTION (provided by applicant): The long-term objective of this project is to understand the signaling mechanisms and physiological functions of the newly discovered Rac-cGMP pathway. Many membrane-signaling receptors can increase the cellular levels of the ubiquitous second messenger cyclic GMP (cGMP). However, the molecular mechanism by which these membrane-signaling receptors increased cGMP was not known. We recently uncovered a new Rac-cGMP signaling pathway. The small G protein Rac uses its effector PAK (p21-activated kinase) to allosterically activate transmembrane guanylyl cyclases (GCs). These findings reveal a general mechanism for diverse signaling receptors to modulate physiological responses through cGMP. Although the kinase activity of PAK is required, PAK does not directly phosphorylate GCs. Instead, autophosphorylation of PAK is needed to maintain its activated configuration. The active form of PAK then allosterically activates transmembrane GCs. The main focus of this application is on the biochemical mechanism by which Rac, through its effector PAK, regulates the activity of transmembrane guanylyl cyclases. We will investigate the allosteric activation of transmembrane guanylyl cyclases by PAK in the Specific Aim 1. In the Specific Aim 2, we will explore the signaling molecules downstream of cGMP. We will investigate the physiological function of the Rac-cGMP pathway in the Specific Aim 3.
PUBLIC HEALTH RELEVANCE: This research is directly related to human health. Both Rac GTPase and the second messenger cGMP are critical regulators of many physiological functions. Cell migration and vascular permeability are essential for vascular development and are involved in cardiovascular diseases. Investigations of the signaling mechanisms and physiological functions of the Rac-cGMP pathway will significantly advance our understanding of cardiovascular function and diseases.
项目描述(由申请人提供):本项目的长期目标是了解新发现的Rac-cGMP通路的信号机制和生理功能。许多膜信号受体可以增加细胞中普遍存在的第二信使环GMP (cGMP)的水平。然而,这些膜信号受体增加cGMP的分子机制尚不清楚。我们最近发现了一个新的Rac-cGMP信号通路。小G蛋白Rac利用其效应物PAK (p21活化激酶)变构激活跨膜观嘌呤环化酶(GCs)。这些发现揭示了多种信号受体通过cGMP调节生理反应的一般机制。虽然PAK的激酶活性是必需的,但PAK并不直接磷酸化GCs。相反,需要PAK的自磷酸化来维持其激活的结构。活性形式的PAK然后变构激活跨膜gc。本应用的主要焦点是Rac通过其效应物PAK调节跨膜观基环化酶活性的生化机制。我们将在Specific Aim 1中研究PAK对跨膜胍基环化酶的变构激活。在Specific Aim 2中,我们将探讨cGMP下游的信号分子。我们将在特异性目的3中探讨Rac-cGMP通路的生理功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xin-Yun Huang其他文献
Xin-Yun Huang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xin-Yun Huang', 18)}}的其他基金
Molecular Basis of B1-Adrenergic Receptor Function
B1-肾上腺素受体功能的分子基础
- 批准号:
10414984 - 财政年份:2020
- 资助金额:
$ 8.45万 - 项目类别:
Molecular Basis of B1-Adrenergic Receptor Function
B1-肾上腺素受体功能的分子基础
- 批准号:
10034746 - 财政年份:2020
- 资助金额:
$ 8.45万 - 项目类别:
Molecular Basis of B1-Adrenergic Receptor Function
B1-肾上腺素受体功能的分子基础
- 批准号:
10618897 - 财政年份:2020
- 资助金额:
$ 8.45万 - 项目类别:
Molecular Basis of B1-Adrenergic Receptor Function
B1-肾上腺素受体功能的分子基础
- 批准号:
10224279 - 财政年份:2020
- 资助金额:
$ 8.45万 - 项目类别:
Migrastatin Analogues and Inhibition of Tumor Metastasis
米格拉他汀类似物及其对肿瘤转移的抑制
- 批准号:
8111229 - 财政年份:2009
- 资助金额:
$ 8.45万 - 项目类别:
相似海外基金
Molecular insights into the allosteric regulation of opioid receptors
阿片受体变构调节的分子见解
- 批准号:
DE240100931 - 财政年份:2024
- 资助金额:
$ 8.45万 - 项目类别:
Discovery Early Career Researcher Award
Allosteric regulation of lysine degradation as a novel pathophysiological mechanism in glutaric aciduria type 1
赖氨酸降解的变构调节作为 1 型戊二酸尿症的一种新的病理生理机制
- 批准号:
10720740 - 财政年份:2023
- 资助金额:
$ 8.45万 - 项目类别:
Elucidating the Mechanism for Allosteric Regulation of SIRT1 through the N-terminal Region
阐明 SIRT1 通过 N 末端区域变构调节的机制
- 批准号:
10627735 - 财政年份:2023
- 资助金额:
$ 8.45万 - 项目类别:
Allosteric Regulation of Actin Capping Protein: Mechanism and Significance
肌动蛋白加帽蛋白的变构调节:机制和意义
- 批准号:
10330809 - 财政年份:2022
- 资助金额:
$ 8.45万 - 项目类别:
Allosteric Regulation of Actin Capping Protein: Mechanism and Significance
肌动蛋白加帽蛋白的变构调节:机制和意义
- 批准号:
10797746 - 财政年份:2022
- 资助金额:
$ 8.45万 - 项目类别:
Structural and functional studies of allosteric regulation of metabolic enzymes
代谢酶变构调节的结构和功能研究
- 批准号:
RGPIN-2020-04281 - 财政年份:2022
- 资助金额:
$ 8.45万 - 项目类别:
Discovery Grants Program - Individual
Allosteric Regulation of Actin Capping Protein: Mechanism and Significance
肌动蛋白加帽蛋白的变构调节:机制和意义
- 批准号:
10552651 - 财政年份:2022
- 资助金额:
$ 8.45万 - 项目类别:
Allosteric regulation of human cystathionine beta-synthase
人胱硫醚β-合酶的变构调节
- 批准号:
10602404 - 财政年份:2022
- 资助金额:
$ 8.45万 - 项目类别:
Allosteric regulation of human cystathionine beta-synthase
人胱硫醚β-合酶的变构调节
- 批准号:
10381000 - 财政年份:2022
- 资助金额:
$ 8.45万 - 项目类别:
Structural basis for allosteric regulation of RyR1
RyR1 变构调节的结构基础
- 批准号:
10366087 - 财政年份:2021
- 资助金额:
$ 8.45万 - 项目类别: